Your Health, We Care

Home >Drug List>Pazopanib>Indications of Pazopanib

Pazopanib(LUCiPazo)

Release date: 2026-10-21 13:48:56     Recommended: 2

Pazopanib (LUCiPazo) is indicated for adult patients with advanced renal cell carcinoma (RCC) and adult patients with advanced soft tissue sarcoma (STS) who have previously received chemotherapy.